Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Iovance Biotherapeutics, Inc. - Common Stock
(NQ:
IOVA
)
4.415
+0.625 (+16.49%)
Streaming Delayed Price
Updated: 2:42 PM EDT, Jun 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iovance Biotherapeutics, Inc. - Common Stock
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
23
24
Next >
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
↗
July 28, 2024
Top mid-cap stocks of the week: ASTS up 47.88%, GSHD up 39.86%, VSAT up 30.78%, VKTX up 29.86%, BEAM up 23.93%, CLDX up 19.72%
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
July 23, 2024
Via
Benzinga
How Is The Market Feeling About Iovance Biotherapeutics?
↗
July 22, 2024
Via
Benzinga
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
July 19, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
What's Going On With Iovance Biotherapeutics Today?
↗
May 24, 2024
On Thursday, Iovance revealed updated clinical findings for lifileucel in conjunction with pembrolizumab as a treatment for frontline advanced melanoma, as well as implementation data, to be presented...
Via
Benzinga
Iovance Biotherapeutics's Options: A Look at What the Big Money is Thinking
↗
May 10, 2024
Via
Benzinga
How Is The Market Feeling About Iovance Biotherapeutics?
↗
May 09, 2024
Via
Benzinga
7 ‘Death Cross’ Stocks That Could Be Contrarian Buys
↗
July 17, 2024
Although death cross stocks sound incredibly ominous, they could be the ideal time to consider a contrarian position.
Via
InvestorPlace
Is Iovance Biotherapeutics a Millionaire Maker?
↗
July 14, 2024
This biotech's future is bright, but how good could it get for investors?
Via
The Motley Fool
3 Under-$10 Biotech Stocks That Could Make You Rich
↗
July 11, 2024
Discover three under-$10 biotech stocks with potential to make you rich with huge returns on investment through an in-depth analysis.
Via
InvestorPlace
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
↗
July 11, 2024
Via
Benzinga
Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
June 28, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Is It Too Late to Buy Iovance Biotherapeutics Stock?
↗
June 28, 2024
The stock is down more than 50% from its 52-week high.
Via
The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
June 21, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
3 Top Penny Stocks to Skyrocket Your Wealth in 2024
↗
June 21, 2024
Find out about the top penny stocks to buy this year for a chance to see incredible results down the road as they soar to new heights.
Via
InvestorPlace
The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why
↗
June 10, 2024
New data indicate that its cell therapy could soon find a larger market.
Via
The Motley Fool
Oncotelic Therapeutics (OTC: OTLC) Inks Deal With Mosaic ImmunoEngineering To Sell Clinical-Stage Necroptosis Cancer Therapy Assets
May 29, 2024
Oncotelic Therapeutics (OTC: OTLC) Inks Deal With Mosaic ImmunoEngineering To Sell Clinical-Stage Necroptosis Cancer Therapy Assets
Via
News Direct
Iovance Biotherapeutics to Present at Upcoming Conferences and Events
May 24, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
May 24, 2024
Via
Benzinga
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
May 23, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
↗
May 22, 2024
These biotech stocks have just launched their first products.
Via
The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
May 17, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
4 Small-Cap Value Stocks That Could Go Parabolic
↗
May 16, 2024
These four small-cap stocks scan as deeply undervalued right now.
Via
The Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy in May 2024
↗
May 11, 2024
Three most undervalued biotech stocks to buy now will take off in the coming years and bring back continuous, hefty returns.
Via
InvestorPlace
Why Iovance Stock Is Down 18% Today
↗
May 10, 2024
Investors are misunderstanding when the biopharma company's flagship drug will begin generating meaningful reportable revenue.
Via
The Motley Fool
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
May 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
May 10, 2024
Via
Benzinga
IOVA Stock Earnings: Iovance Biotherapeutics Meets EPS, Misses Revenue for Q1 2024
↗
May 09, 2024
IOVA stock results show that Iovance Biotherapeutics met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
May 09, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Got $500? These Hot Growth Stocks Are Screaming Buys Right Now
↗
May 05, 2024
The time to jump into a red-hot growth prospect is usually right now...before any more investors identify the opportunity.
Via
The Motley Fool
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
23
24
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
